Gary Ingenito, Chief Medical and Regulatory Officer at Catalyst Pharmaceuticals ($CPRX), sold about $5.8 million in company shares through two open market transactions over the past year. His most recent sale occurred on May 14, 2025. These sales rank him 1,743rd among 11,678 insiders by total value sold, below the average of $8.6 million across about 6.4 transactions per insider. Ingenito made no open market purchases in this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 13, 2025 | CATALYST PHARMACEUTICALS, INC. | $CPRX | INGENITO GARY | Chief Med. & Reg. Officer | M | Common stock, par value $0.001 per share | 200000 | $3.42 | 268,873.0000 | 124,943,603 | 290.39% | 0.16% |
| May 13, 2025 | CATALYST PHARMACEUTICALS, INC. | $CPRX | INGENITO GARY | Chief Med. & Reg. Officer | S | Common stock, par value $0.001 per share | 200000 | $23.68 | 68,873.0000 | 124,943,603 | 74.38% | 0.16% |
| May 14, 2025 | CATALYST PHARMACEUTICALS, INC. | $CPRX | INGENITO GARY | Chief Med. & Reg. Officer | M | Common stock, par value $0.001 per share | 44000 | $4.64 | 112,873.0000 | 124,943,603 | 63.89% | 0.04% |
| May 14, 2025 | CATALYST PHARMACEUTICALS, INC. | $CPRX | INGENITO GARY | Chief Med. & Reg. Officer | S | Common stock, par value $0.001 per share | 44000 | $23.63 | 68,873.0000 | 124,943,603 | 38.98% | 0.04% |
| May 13, 2025 | CATALYST PHARMACEUTICALS, INC. | $CPRX | INGENITO GARY | Chief Med. & Reg. Officer | M | Options to purchase common stock | 200000 | $0.00 | 590,282.0000 | 124,943,603 | 25.31% | 0.16% |
| May 14, 2025 | CATALYST PHARMACEUTICALS, INC. | $CPRX | INGENITO GARY | Chief Med. & Reg. Officer | M | Options to purchase common stock | 44000 | $0.00 | 546,282.0000 | 124,943,603 | 7.45% | 0.04% |
| March 5, 2025 | CATALYST PHARMACEUTICALS, INC. | $CPRX | INGENITO GARY | Chief Med. & Reg. Officer | M | Common stock, par value $0.001 per share | 44904 | $2.24 | 113,777.0000 | 124,943,603 | 65.20% | 0.04% |
| March 5, 2025 | CATALYST PHARMACEUTICALS, INC. | $CPRX | INGENITO GARY | Chief Med. & Reg. Officer | S | Common stock, par value $0.001 per share | 44904 | $22.09 | 68,873.0000 | 124,943,603 | 39.47% | 0.04% |
| March 6, 2025 | CATALYST PHARMACEUTICALS, INC. | $CPRX | INGENITO GARY | Chief Med. & Reg. Officer | M | Common stock, par value $0.001 per share | 180096 | $2.24 | 248,969.0000 | 124,943,603 | 261.49% | 0.14% |
| March 6, 2025 | CATALYST PHARMACEUTICALS, INC. | $CPRX | INGENITO GARY | Chief Med. & Reg. Officer | S | Common stock, par value $0.001 per share | 180096 | $21.67 | 68,873.0000 | 124,943,603 | 72.34% | 0.14% |
| March 5, 2025 | CATALYST PHARMACEUTICALS, INC. | $CPRX | INGENITO GARY | Chief Med. & Reg. Officer | M | Options to purchase common stock | 44904 | $0.00 | 970,378.0000 | 124,943,603 | 4.42% | 0.04% |
| March 6, 2025 | CATALYST PHARMACEUTICALS, INC. | $CPRX | INGENITO GARY | Chief Med. & Reg. Officer | M | Options to purchase common stock | 180096 | $0.00 | 790,282.0000 | 124,943,603 | 18.56% | 0.14% |
| Feb. 14, 2025 | CATALYST PHARMACEUTICALS, INC. | $CPRX | INGENITO GARY | Chief Med. & Reg. Officer | M | Common Stock, par value $0.001 per share | 10000 | $0.00 | 71,308.0000 | 124,943,603 | 16.31% | 0.01% |
| Feb. 14, 2025 | CATALYST PHARMACEUTICALS, INC. | $CPRX | INGENITO GARY | Chief Med. & Reg. Officer | F | Common Stock, par value $0.001 per share | 2435 | $0.00 | 68,873.0000 | 124,943,603 | 3.41% | 0.00% |
| Feb. 14, 2025 | CATALYST PHARMACEUTICALS, INC. | $CPRX | INGENITO GARY | Chief Med. & Reg. Officer | M | Restricted Stock Units | 10000 | $0.00 | 1,015,282.0000 | 124,943,603 | 0.98% | 0.01% |
| Dec. 27, 2024 | CATALYST PHARMACEUTICALS, INC. | $CPRX | INGENITO GARY | Chief Med. & Reg. Officer | M | Common Stock, par value $0.001 per share | 9000 | $0.00 | 64,849.0000 | 125,407,279 | 16.11% | 0.01% |
| Dec. 27, 2024 | CATALYST PHARMACEUTICALS, INC. | $CPRX | INGENITO GARY | Chief Med. & Reg. Officer | F | Common Stock, par value $0.001 per share | 3541 | $0.00 | 61,308.0000 | 125,407,279 | 5.46% | 0.00% |
| Dec. 27, 2024 | CATALYST PHARMACEUTICALS, INC. | $CPRX | INGENITO GARY | Chief Med. & Reg. Officer | M | Restricted Stock Units | 9000 | $0.00 | 1,025,282.0000 | 125,407,279 | 0.87% | 0.01% |
| Dec. 9, 2024 | CATALYST PHARMACEUTICALS, INC. | $CPRX | INGENITO GARY | Chief Med. & Reg. Officer | M | Common Stock, par value $0.001 per share | 7349 | $0.00 | 58,740.0000 | 125,407,279 | 14.30% | 0.01% |
| Dec. 9, 2024 | CATALYST PHARMACEUTICALS, INC. | $CPRX | INGENITO GARY | Chief Med. & Reg. Officer | F | Common Stock, par value $0.001 per share | 2891 | $0.00 | 55,849.0000 | 125,407,279 | 4.92% | 0.00% |
| Dec. 9, 2024 | CATALYST PHARMACEUTICALS, INC. | $CPRX | INGENITO GARY | Chief Med. & Reg. Officer | M | Restricted Stock Units | 7349 | $0.00 | 1,034,282.0000 | 125,407,279 | 0.71% | 0.01% |
| Nov. 27, 2024 | CATALYST PHARMACEUTICALS, INC. | $CPRX | INGENITO GARY | Chief Med. & Reg. Officer | M | Common stock, par value $0.001 per share | 12000 | $4.01 | 63,391.0000 | 125,407,279 | 23.35% | 0.01% |
| Nov. 27, 2024 | CATALYST PHARMACEUTICALS, INC. | $CPRX | INGENITO GARY | Chief Med. & Reg. Officer | S | Common stock, par value $0.001 per share | 8631 | $22.74 | 54,760.0000 | 125,407,279 | 13.62% | 0.01% |
| Nov. 27, 2024 | CATALYST PHARMACEUTICALS, INC. | $CPRX | INGENITO GARY | Chief Med. & Reg. Officer | S | Common stock, par value $0.001 per share | 3369 | $22.67 | 51,391.0000 | 125,407,279 | 6.15% | 0.00% |
| Nov. 27, 2024 | CATALYST PHARMACEUTICALS, INC. | $CPRX | INGENITO GARY | Chief Med. & Reg. Officer | M | Options to purchase common stock | 12000 | $0.00 | 1,041,631.0000 | 125,407,279 | 1.14% | 0.01% |
| Nov. 21, 2024 | CATALYST PHARMACEUTICALS, INC. | $CPRX | INGENITO GARY | Chief Med. & Reg. Officer | A | Options to purchase common stock | 125696 | $0.00 | 1,038,271.0000 | 125,407,279 | 13.77% | 0.10% |
| Nov. 21, 2024 | CATALYST PHARMACEUTICALS, INC. | $CPRX | INGENITO GARY | Chief Med. & Reg. Officer | A | Restricted Stock Units | 15360 | $0.00 | 1,053,631.0000 | 125,407,279 | 1.48% | 0.01% |
| Nov. 20, 2024 | CATALYST PHARMACEUTICALS, INC. | $CPRX | INGENITO GARY | Chief Med. & Reg. Officer | M | Common stock, par value $0.001 per share | 38000 | $4.01 | 89,391.0000 | 125,407,279 | 73.94% | 0.03% |
| Nov. 20, 2024 | CATALYST PHARMACEUTICALS, INC. | $CPRX | INGENITO GARY | Chief Med. & Reg. Officer | S | Common stock, par value $0.001 per share | 38000 | $21.20 | 51,391.0000 | 125,407,279 | 42.51% | 0.03% |
| Nov. 20, 2024 | CATALYST PHARMACEUTICALS, INC. | $CPRX | INGENITO GARY | Chief Med. & Reg. Officer | M | Options to purchase common stock | 38000 | $0.00 | 912,575.0000 | 125,407,279 | 4.00% | 0.03% |
| Aug. 9, 2024 | CATALYST PHARMACEUTICALS, INC. | $CPRX | INGENITO GARY | Chief Med. & Reg. Officer | M | Common stock, par value $0.001 per share | 100000 | $4.01 | 151,391.0000 | 113,753,154 | 194.59% | 0.09% |
| Aug. 9, 2024 | CATALYST PHARMACEUTICALS, INC. | $CPRX | INGENITO GARY | Chief Med. & Reg. Officer | S | Common stock, par value $0.001 per share | 100000 | $18.04 | 51,391.0000 | 113,753,154 | 66.05% | 0.09% |
| Aug. 9, 2024 | CATALYST PHARMACEUTICALS, INC. | $CPRX | INGENITO GARY | Chief Med. & Reg. Officer | M | Options to purchase common stock | 100000 | $0.00 | 950,575.0000 | 113,753,154 | 9.52% | 0.09% |
| June 5, 2024 | CATALYST PHARMACEUTICALS, INC. | $CPRX | INGENITO GARY | Chief Med. & Reg. Officer | M | Common stock, par value $0.001 per share | 80000 | $4.01 | 131,391.0000 | 113,753,154 | 155.67% | 0.07% |
| June 5, 2024 | CATALYST PHARMACEUTICALS, INC. | $CPRX | INGENITO GARY | Chief Med. & Reg. Officer | S | Common stock, par value $0.001 per share | 80000 | $16.16 | 51,391.0000 | 113,753,154 | 60.89% | 0.07% |
| June 5, 2024 | CATALYST PHARMACEUTICALS, INC. | $CPRX | INGENITO GARY | Chief Med. & Reg. Officer | M | Options to purchase common stock | 80000 | $0.00 | 1,050,575.0000 | 113,753,154 | 7.08% | 0.07% |
| Feb. 15, 2024 | CATALYST PHARMACEUTICALS, INC. | $CPRX | INGENITO GARY | Chief Med. & Reg. Officer | M | Common Stock, par value $0.001 per share | 10000 | $0.00 | 53,826.0000 | 113,753,154 | 22.82% | 0.01% |
| Feb. 15, 2024 | CATALYST PHARMACEUTICALS, INC. | $CPRX | INGENITO GARY | Chief Med. & Reg. Officer | F | Common Stock, par value $0.001 per share | 2435 | $0.00 | 51,391.0000 | 113,753,154 | 4.52% | 0.00% |
| Feb. 15, 2024 | CATALYST PHARMACEUTICALS, INC. | $CPRX | INGENITO GARY | Chief Med. & Reg. Officer | M | Restricted Stock Units | 10000 | $0.00 | 1,130,575.0000 | 113,753,154 | 0.88% | 0.01% |
| Dec. 27, 2023 | CATALYST PHARMACEUTICALS, INC. | $CPRX | INGENITO GARY | Chief Med. & Reg. Officer | M | Common Stock, par value $0.001 per share | 9000 | $0.00 | 47,367.0000 | 111,375,631 | 23.46% | 0.01% |
| Dec. 27, 2023 | CATALYST PHARMACEUTICALS, INC. | $CPRX | INGENITO GARY | Chief Med. & Reg. Officer | F | Common Stock, par value $0.001 per share | 3541 | $0.00 | 43,826.0000 | 111,375,631 | 7.48% | 0.00% |
| Dec. 27, 2023 | CATALYST PHARMACEUTICALS, INC. | $CPRX | INGENITO GARY | Chief Med. & Reg. Officer | M | Restricted Stock Units | 9000 | $0.00 | 1,140,575.0000 | 111,375,631 | 0.78% | 0.01% |
| Dec. 8, 2023 | CATALYST PHARMACEUTICALS, INC. | $CPRX | INGENITO GARY | Chief Med. & Reg. Officer | A | Options to purchase common stock | 153526 | $0.00 | 1,127,526.0000 | 111,375,631 | 15.76% | 0.14% |
| Dec. 8, 2023 | CATALYST PHARMACEUTICALS, INC. | $CPRX | INGENITO GARY | Chief Med. & Reg. Officer | A | Restricted Stock Units | 22049 | $0.00 | 1,149,575.0000 | 111,375,631 | 1.96% | 0.02% |
| Dec. 6, 2023 | CATALYST PHARMACEUTICALS, INC. | $CPRX | INGENITO GARY | Chief Med. & Reg. Officer | M | Common stock, par value $0.001 per share | 50000 | $1.13 | 88,367.0000 | 111,375,631 | 130.32% | 0.04% |
| Dec. 6, 2023 | CATALYST PHARMACEUTICALS, INC. | $CPRX | INGENITO GARY | Chief Med. & Reg. Officer | S | Common stock, par value $0.001 per share | 50000 | $14.02 | 38,367.0000 | 111,375,631 | 56.58% | 0.04% |
| Dec. 6, 2023 | CATALYST PHARMACEUTICALS, INC. | $CPRX | INGENITO GARY | Chief Med. & Reg. Officer | M | Options to purchase common stock | 50000 | $0.00 | 974,000.0000 | 111,375,631 | 4.88% | 0.04% |
| Feb. 15, 2023 | CATALYST PHARMACEUTICALS, INC. | $CPRX | INGENITO GARY | Chief Medical Officer | M | Common Stock, par value $0.001 per share | 10000 | $0.00 | 40,802.0000 | 111,375,631 | 32.47% | 0.01% |
| Feb. 15, 2023 | CATALYST PHARMACEUTICALS, INC. | $CPRX | INGENITO GARY | Chief Medical Officer | F | Common Stock, par value $0.001 per share | 2435 | $0.00 | 38,367.0000 | 111,375,631 | 5.97% | 0.00% |
| Feb. 15, 2023 | CATALYST PHARMACEUTICALS, INC. | $CPRX | INGENITO GARY | Chief Medical Officer | M | Restricted Stock Units | 10000 | $0.00 | 1,024,000.0000 | 111,375,631 | 0.99% | 0.01% |